BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G Report for Lexeo Therapeutics, Inc. Common Stock (LXEO)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lexeo Therapeutics, Inc. Common Stock
Symbol: LXEO
Shares outstanding: 33,126,655 shares
Disclosed Ownership: 1,821,966 shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Filing time: 04 Feb 2025, 15:45:44 UTC
Date of event: 31 Dec 2024
Next filing: 17 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.5%	1,821,966	1,804,571	0	Spencer Fleming	Managing Director